
|Articles|January 24, 2005
This IV eases mucositis misery in transplant patients
Relief is finally at hand for patients with leukemia or lymphoma who must undergo extremely high dose chemotherapy and radiation to prep for bone marrow transplant. A new agent will reduce their chances of developing mucositis-severe ulceration of the oral mucosa caused by the cancer treatments themselves.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Optimizing MTM Services for Patients With Cardiometabolic Conditions: A Practical Guide for Pharmacists
2
Wicked Good Cardiometabolic Chat: Identifying and Managing MASH
3
Study Links Antipsychotic Use to Rapid Rise in Youth Type 2 Diabetes
4
Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits
5






















